Expression of immune checkpoint protein in oral squamous cell carcinoma and its clinicopathological correlation: A tertiary care center cross-sectional study

BACKGROUND: Recent evidence suggests that oral squamous cell carcinoma (OSCC) patients who exhibit the immunohistochemical expression of immune checkpoint protein programmed cell death ligand 1 (PD-L1) are more likely to have a poor clinical outcome and may serve as an independent prognostic marker....

Descripción completa

Detalles Bibliográficos
Autores principales: Ratnakar, Sonal, Kumar, Madhu, Maurya, Malti K., Qayoom, Sumaira, Sagar, Mala, Babu, Suresh, Kumar, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683904/
https://www.ncbi.nlm.nih.gov/pubmed/38033955
http://dx.doi.org/10.4103/jomfp.jomfp_169_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683904/
https://www.ncbi.nlm.nih.gov/pubmed/38033955
http://dx.doi.org/10.4103/jomfp.jomfp_169_22

Ejemplares similares